Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study.

Kristina KihlbergFariba BaghaeiMaria BruzeliusEva FundingPål Andre HolmeRiitta LassilaVuokko Nummi Susanna Ranta Mehdi Osooli Erik Berntorp Jan Astermark

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)

The Nordic cohort of PwHB is well treated by prophylaxis, but the goal of zero bleeds for all is not reached. Our findings suggest that patients with severe HB suffer from a milder arthropathy than patients with severe HA.

Keyphrases

early onset
drug induced